{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:51:52Z","timestamp":1778903512130,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis is a multifactorial autoimmune disease, which underlies the abnormalities of the apoptotic process. In cases of psoriasis and psoriatic arthritis, biological treatment is used. This study aimed to determine any changes in the expression of the genes associated with apoptosis in patients with psoriatic arthritis treated with adalimumab and to assess any phenotypic modifications based on changes in dermatological indexes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 20 patients with psoriatic arthritis treated biologically and 20 healthy volunteers. The research material consisted of peripheral blood mononuclear cells (PBMCs) from which the total RNA was isolated. Changes in the gene expression were determined using oligonucleotide microarrays and RT-qPCR. The clinical condition was assessed based on selected indicators: PASI, BSA [%], DAS28, and DLQI, which were determined every 3\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were changes in the expression of genes associated with apoptosis. Significant differences were found for <jats:italic>ROCK1<\/jats:italic>, <jats:italic>RhoA<\/jats:italic>, and <jats:italic>LIMK2<\/jats:italic> expression profiles in PBMCs. At the initial stage of treatment, a decrease in the PASI and BSA rates was observed. At the later stages, the values of these indicators increased once again. There were correlations between the changes in these genes\u2019 expression and the dermatological markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Adalimumab influences the expression of genes related to apoptosis and the values of dermatological indicators of patients. Changes in the expression level of genes associated with apoptosis suggest that <jats:italic>ROCK1<\/jats:italic>, <jats:italic>RhoA<\/jats:italic>, and <jats:italic>LIMK2<\/jats:italic> may be genes that can potentially be indicators of treatment effectiveness and lack of response to biological treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s43440-020-00068-4","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T13:03:08Z","timestamp":1583154188000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment"],"prefix":"10.1007","volume":"72","author":[{"given":"Agata","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Strza\u0142ka-Mrozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beniamin","family":"Grabarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Wcis\u0142o-Dziadecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kimsa-Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina","family":"Kruszniewska-Rajs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Gola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"68_CR1","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3390\/ijms17010010","volume":"17","author":"H Guo","year":"2016","unstructured":"Guo H, Chen L, Cui H, Peng X, Fang J, Zuo Z, et al. Research advances on pathways of nickel-induced apoptosis. Int J Mol Sci. 2016;17:E10.","journal-title":"Int J Mol Sci."},{"key":"68_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jid.5700008","volume":"126","author":"D Raj","year":"2006","unstructured":"Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol. 2006;126:243\u201357.","journal-title":"J Invest Dermatol"},{"key":"68_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5114\/dr.2017.66223","volume":"104","author":"H My\u015bliwiec","year":"2017","unstructured":"My\u015bliwiec H, Baran A, Flisiak I. Selected aspects of apoptosis in psoriasis. Dermatol Rev. 2017;104:57\u201363.","journal-title":"Dermatol Rev"},{"key":"68_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15713\/ins.jmrps.68","volume":"3","author":"S Nambiar","year":"2016","unstructured":"Nambiar S, Hegde V. Apoptosis in cancer therapy. J Med Radiol Pathol Surg. 2016;3:10\u20134.","journal-title":"J Med Radiol Pathol Surg"},{"key":"68_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/cmi.2017.136","volume":"15","author":"H Lou","year":"2018","unstructured":"Lou H, Pickering M. Extracellular DNA and autoimmune disease. Cell Mol Immunol. 2018;15:746\u201355.","journal-title":"Cell Mol Immunol"},{"key":"68_CR6","first-page":"3","volume":"10","author":"S Ray","year":"2012","unstructured":"Ray S, Sonthalia N, Kundu S, Ganguly S. Autoimmune disorders: an overview of molecular and cellular basic in today\u2019s perspective. J Clin Cell Immunol. 2012;10:3.","journal-title":"J Clin Cell Immunol"},{"issue":"3","key":"68_CR7","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.4049\/jimmunol.170.3.1566","volume":"170","author":"K Sperber","year":"2003","unstructured":"Sperber K, Beuria P, Singha N, Gelman I, Cortes P, Chen H, et al. Induction of apoptosis by HIV-1-infected monocytic cells. J Immunol. 2003;170(3):1566\u201378.","journal-title":"J Immunol"},{"issue":"3","key":"68_CR8","first-page":"146","volume":"10","author":"K Gojniczek","year":"2007","unstructured":"Gojniczek K, Jurzak M, Boryka M, Garncarczyk A. Keratosis of the epidermis as an effect of keratinocyte proliferation, differentiation and apoptosis. Pol J Cosmetol. 2007;10(3):146\u201355.","journal-title":"Pol J Cosmetol"},{"key":"68_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1365-2567.2000.00074.x","volume":"100","author":"J Gordon","year":"2000","unstructured":"Gordon J, Pound JD. Fortifying B cells with CD154: an engaging tale of many hues. Immunology. 2000;100:269\u201380.","journal-title":"Immunology"},{"issue":"1","key":"68_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, Nanchahal J, Taylor P, Feldmann M. Anti-TNF therapy: past, present and future. Int Immunol. 2015;27(1):55\u201362.","journal-title":"Int Immunol"},{"key":"68_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.5604\/01.3001.0012.2026","volume":"72","author":"A Partyka","year":"2018","unstructured":"Partyka A, Czopek A, Stanisz-Wallis K, Zag\u00f3rska A. The use of biopharmaceuticals in the treatment of psoriasis. Post Hig Med Dosw. 2018;72:642\u201358.","journal-title":"Post Hig Med Dosw"},{"issue":"9","key":"68_CR12","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3389\/fimmu.2018.01668","volume":"13","author":"G Caiazzo","year":"2018","unstructured":"Caiazzo G, Fabbrocini G, Di Caprio R, Raimondo A, Scala E, Balato N, et al. Psoriasis, cardiovascular events and biologics: lights and shadows. Front Immunol. 2018;13(9):1668.","journal-title":"Front Immunol"},{"issue":"11","key":"68_CR13","first-page":"1363","volume":"17","author":"A Balato","year":"2017","unstructured":"Balato A, Scala E, Balato N, Caiazzo G, Di Caprio R, Monfrecola G, et al. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders. Expert Opin Biol Ther. 2017;17(11):1363\u201374.","journal-title":"Expert Opin Biol Ther"},{"key":"68_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5114\/dr.2018.79175","volume":"105","author":"D Wcis\u0142o-Dziadecka","year":"2018","unstructured":"Wcis\u0142o-Dziadecka D, Grabarek B, Brzezi\u0144ska-Wcis\u0142o L, Mazurek U. Drug resistance in anti-TNF therapy of psoriatic arthritis. Dermatol Rev. 2018;105:625\u201331.","journal-title":"Dermatol Rev"},{"key":"68_CR15","first-page":"1","volume":"97","author":"J Szepietowski","year":"2010","unstructured":"Szepietowski J, Adamski Z, Chodorowska G, Gli\u0144ski W, Kaszuba A, Placek W, et al. Guidelines of Polish dermatological Society on the treatment of psoriasis vulgaris and arthropathic psoriasis (psoriatic arthritis) with biological drugs. Dermatol Rev. 2010;97:1\u20133.","journal-title":"Dermatol Rev"},{"issue":"5","key":"68_CR16","doi-asserted-by":"publisher","first-page":"e0217352","DOI":"10.1371\/journal.pone.0217352","volume":"14","author":"NY Sahlol","year":"2019","unstructured":"Sahlol NY, Mostafa MS, Madkour LAE, Salama DM. Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity. PLoS One. 2019;14(5):e0217352.","journal-title":"PLoS One"},{"key":"68_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbacli.2016.06.002","volume":"6","author":"S Arul","year":"2016","unstructured":"Arul S, Dayalan H, Jegadeesan M, Damonharan P. Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose. BBA Clin. 2016;6:82\u20136.","journal-title":"BBA Clin"},{"key":"68_CR18","first-page":"110","volume":"62","author":"J Nowak","year":"2008","unstructured":"Nowak J, Grzanka A, \u017bury\u0144 A, St\u0119pie\u0144 A. The Rho protein family and its role in the cellular cytoskeleton. Post Hig Med Dosw (online). 2008;62:110\u20137.","journal-title":"Post Hig Med Dosw (online)"},{"issue":"4","key":"68_CR19","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1091\/mbc.e05-12-1173","volume":"17","author":"M Honma","year":"2006","unstructured":"Honma M, Benitah SA, Watt FM. Role of LIM kinases in normal and psoriatic human epidermis. Mol Biol Cell. 2006;17(4):1888\u2013966.","journal-title":"Mol Biol Cell"},{"key":"68_CR20","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/OTT.S152238","volume":"11","author":"X Yang","year":"2018","unstructured":"Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, et al. Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis. OncoTargets Ther. 2018;11:1457\u201374.","journal-title":"OncoTargets Ther"},{"key":"68_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fmed.2019.00045","volume":"6","author":"L Ouboussad","year":"2019","unstructured":"Ouboussad L, Burska A, Melville A, Buch M. Synovial tissue heterogeneity in rheumatoid arthritis and changes with biologic and targeted synthetic therapies to inform stratified therapy. Front Med (Lausanne). 2019;6:45.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"68_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13075-019-1862-6","volume":"21","author":"S P\u00f3liska","year":"2019","unstructured":"P\u00f3liska S, Besenyei T, Vegh E, Hamar A, Pusztai A, Vancsa A, et al. Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):94.","journal-title":"Arthritis Res Ther"},{"key":"68_CR23","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.12659\/MSM.916762","volume":"25","author":"K Dziobek","year":"2019","unstructured":"Dziobek K, Op\u0142awski M, Grabarek B, Zmarz\u0142y N, Januszyk P, Adwent I, et al. Expression of semaphorin 3B (SEMA3B) in various grades of endometrial cancer. Med Sci Monit. 2019;25:4569\u201374.","journal-title":"Med Sci Monit"},{"key":"68_CR24","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1210\/jc.2018-01348","volume":"12","author":"J Lippert","year":"2018","unstructured":"Lippert J, Appemzeller A, Liang R, Sbiera S, Kircher S, Altieri B, et al. Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication. J Clin Endocrinol Metab. 2018;12:4511\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"68_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/cge.13186","volume":"93","author":"S Tavakolpour","year":"2018","unstructured":"Tavakolpour S, Darvishi M, Ghasemiadl M. Pharmacogenetics: a strategy for personalized medicine for autoimmune diseases. Clin Genet. 2018;93(3):481\u201397.","journal-title":"Clin Genet"},{"issue":"2","key":"68_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5114\/dr.2018.75580","volume":"105","author":"A Reich","year":"2018","unstructured":"Reich A, Adamski Z, Chodorowska G, Kaszuba A, Krasowska D, Lesiak A, et al. Psoriasis. Diagnostic and therapeutic recommendations of the polish dermatological society. Part I: mild psoriasis. Dermatol Rev. 2018;105(2):225\u201343.","journal-title":"Dermatol Rev"},{"issue":"3","key":"68_CR27","first-page":"329","volume":"105","author":"A Reich","year":"2018","unstructured":"Reich A, Szepietowski J, Adamski Z, Chodorowska G, Kaszuba A, Krasowska D, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish dermatological society. Part II: moderate to severe psoriasis. Dermatol Rev. 2018;105(3):329\u201357.","journal-title":"Dermatol Rev"},{"issue":"1\u201312","key":"68_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2119\/2006-00003.Gulko","volume":"11","author":"FM Batliwalla","year":"2005","unstructured":"Batliwalla FM, Li W, Ritchlin CT, Brenner M, Laragione T, Shao T, et al. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med. 2005;11(1\u201312):21\u20139.","journal-title":"Mol Med"},{"key":"68_CR29","first-page":"1579","volume":"125","author":"YW Heng","year":"2012","unstructured":"Heng YW, Lim HH, Mina T, Utomo P, Zhong S, Lim CT, Koh CG. TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation. J Cell Sci. 2012;125:1579\u201390.","journal-title":"J Cell Sci"},{"issue":"4","key":"68_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41419-019-1497-1","volume":"10","author":"T Ren","year":"2019","unstructured":"Ren T, Zheng B, Huang Y, Wang S, Bao X, Liu K, et al. Osteosarcoma cell intrinsic PD-L2 signals promotes invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways. Cell Death Dis. 2019;10(4):261.","journal-title":"Cell Death Dis"},{"key":"68_CR31","doi-asserted-by":"publisher","first-page":"e29846","DOI":"10.4161\/sgtp.29846","volume":"5","author":"L Julian","year":"2014","unstructured":"Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions. Small GTPases. 2014;5:e29846.","journal-title":"Small GTPases"},{"issue":"2","key":"68_CR32","first-page":"121","volume":"1705","author":"SA Benitah","year":"2004","unstructured":"Benitah SA, Valeoron PF, van Aelst L, Matshall CJ, Lacal JC. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochem Biophys Acta. 2004;1705(2):121\u201332.","journal-title":"Biochem Biophys Acta"},{"issue":"3","key":"68_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ncb1230","volume":"7","author":"S Wilkinson","year":"2005","unstructured":"Wilkinson S, Peterson HF, Marshall CJ. Cdc42\u2013MRCK and Rho\u2013ROCK signaling cooperates in myosin phosphorylation and cell invasion. Nat Cell Biol. 2005;7(3):255\u201361.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"68_CR34","doi-asserted-by":"publisher","first-page":"21575","DOI":"10.1002\/jcp.28784","volume":"234","author":"P Zafari","year":"2019","unstructured":"Zafari P, Rafiei A, Esmaeili SA, Moonesi M, Taghadosi M. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J Cell Physiol. 2019;234(2):21575\u201387.","journal-title":"J Cell Physiol"},{"issue":"4","key":"68_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5114\/ada.2018.77673","volume":"35","author":"D Wcis\u0142o-Dziadecka","year":"2018","unstructured":"Wcis\u0142o-Dziadecka D, Gola J, Grabarek B, Mazurek U, Brzezi\u0144ska-Wcis\u0142o L, Kucharz E. Effect of adalimumab on the expression of genes encoding TNF-\u03b1 signal paths in skin fibroblasts in vitro. Adv Dermatol Allergol. 2018;35(4):413\u201322.","journal-title":"Adv Dermatol Allergol"},{"key":"68_CR36","doi-asserted-by":"publisher","first-page":"16636","DOI":"10.1038\/s41598-018-35109-9","volume":"8","author":"W Chen","year":"2018","unstructured":"Chen W, Nyuydzefe M, Weiss J, Jingya Z, Waksal S, Zanin-Zhorov A. ROCK2, but not ROCK1 interact with phosphorylated STAT3 and co-occupies TH17\/TFH gene promoters in TH17-activated human T cells. Sci Rep. 2018;8:16636.","journal-title":"Sci Rep"},{"key":"68_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","volume":"2","author":"J Parmentier","year":"2018","unstructured":"Parmentier J, Voss J, Graff C, Schwartz A, Argiriadi M, Friedman M, et al. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatol. 2018;2:23.","journal-title":"BMC Rheumatol"},{"issue":"4","key":"68_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/cam4.1019","volume":"6","author":"SK Dasgupta","year":"2017","unstructured":"Dasgupta SK, Le A, Vijayan KV, Thiagarajan P. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway. Cancer Med. 2017;6(4):809\u201318.","journal-title":"Cancer Med"},{"key":"68_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.intimp.2017.03.007","volume":"46","author":"F Wei","year":"2017","unstructured":"Wei F, Liu S, Luo L, Gu N, Zeng Y, Chen X, et al. Anti-inflammatory mechanism of ulinastatin: inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-\u03b1 via the RhoA\/ROCK signal pathway. Int Immunopharmacol. 2017;46:220\u20137.","journal-title":"Int Immunopharmacol"},{"key":"68_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pupt.2018.04.004","volume":"50","author":"C Li","year":"2018","unstructured":"Li C, Liu PP, Tang DD, Song R, Zhang YQ, Lei S, et al. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension. Pulm Pharmacol Ther. 2018;50:111\u201322.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"68_CR41","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s12026-016-8794-x","volume":"64","author":"R Ganesan","year":"2016","unstructured":"Ganesan R, Doss HM, Rasool M. Majoon ushba, a polyherbal compound, suppresses pro-inflammatory mediators and RANKL expression via modulating NF\u03baB and MAPKs signaling pathways in fibroblast-like synoviocytes from adjuvant-induced arthritic rats. Immunol Res. 2016;64(4):1071\u201386.","journal-title":"Immunol Res"},{"key":"68_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molimm.2017.08.024","volume":"91","author":"YR Liu","year":"2017","unstructured":"Liu YR, Yan X, Yu HX, Yao Y, Wang JQ, Li XF, et al. NLRC5 promotes cell proliferation via regulating the NF-\u03baB signaling pathway in rheumatoid arthritis. Mol Immunol. 2017;91:24\u201334.","journal-title":"Mol Immunol"},{"issue":"4","key":"68_CR43","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.bbrc.2011.07.031","volume":"411","author":"D Kawanami","year":"2011","unstructured":"Kawanami D, Matova K, Kanazawa Y, Ishizawa S, Yokota T, Utsunomiya K. Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK\/NF-\u03baB signaling pathway activation in vascular endothelial cells. Biochem Biophys Res Commun. 2011;411(4):798\u2013803.","journal-title":"Biochem Biophys Res Commun"},{"key":"68_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fphar.2018.00105","volume":"9","author":"R Deng","year":"2018","unstructured":"Deng R, Li F, Wu H, Wang WY, Dai L, Zhang ZR, et al. Anti-inflammatory mechanism of geniposide: inhibiting the hyperpermeability of fibroblast-like synoviocytes via the RhoA\/p38MAPK\/NF-\u03baB\/F-actin signal pathway. Front Pharmacol. 2018;9:105.","journal-title":"Front Pharmacol"},{"issue":"3","key":"68_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10456-011-9221-5","volume":"14","author":"B Kumar","year":"2011","unstructured":"Kumar B, Chile SA, Ray KB, Reddy GE, Addepalli MK, Kumar AS, et al. EGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway. Angiogenesis. 2011;14(3):371\u201380.","journal-title":"Angiogenesis"},{"issue":"6","key":"68_CR46","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/hep.23931","volume":"52","author":"IJ Cho","year":"2010","unstructured":"Cho IJ, Kim YW, Han CY, Kim EH, Anderson RA, Lee YS, et al. E-cadherin antagonizes transforming growth factor \u03b21 gene induction in hepatic stellate cells by inhibiting RhoA\u2013dependent Smad3 phosphorylation. Hepatology. 2010;52(6):2053\u201364.","journal-title":"Hepatology"},{"issue":"11\u201312","key":"68_CR47","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00018-016-2208-z","volume":"73","author":"K Kunzelmann","year":"2016","unstructured":"Kunzelmann K. Ion channels in regulated cell death. Cell Mol Life Sci. 2016;73(11\u201312):2387\u2013403.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"68_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/bbrc.1997.7409","volume":"239","author":"DJ McConkey","year":"1997","unstructured":"McConkey DJ, Orrenius S. The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun. 1997;239(2):357\u201366.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"68_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/labinvest.2009.111","volume":"90","author":"CT Appleton","year":"2010","unstructured":"Appleton CT, Usmani SE, Mort JS, Beier F. Rho\/ROCK and MEK\/ERK activation by transforming growth factor-\u03b1 induces articular cartilage degradation. Lab Invest. 2010;90(1):20\u201330.","journal-title":"Lab Invest"},{"issue":"2","key":"68_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0898-6568(03)00133-5","volume":"16","author":"G Nebl","year":"2004","unstructured":"Nebl G, Fischer S, Penzel R, Samstag Y. Dephosphorylation of cofilin is regulated through Ras and requires the combined activities of the Ras-effectors MEK and PI3K. Cell Signal. 2004;16(2):235\u201343.","journal-title":"Cell Signal"},{"issue":"8","key":"68_CR51","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a \"synovio-entheseal complex\" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 2007;56(8):2482\u201391.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"68_CR52","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jamadermatol.2018.0141","volume":"154","author":"R Thomi","year":"2018","unstructured":"Thomi R, Cazzaniga S, Seyed Jafari SM, Schlapbach C, Hunger RE. Association of hidradenitis suppurativa with T helper 1\/T helper 17 phenotypes: a semantic map analysis. JAMA Dermatol. 2018;154(5):592\u20135.","journal-title":"JAMA Dermatol"},{"key":"68_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcdb.2017.07.022","volume":"73","author":"C Rianna","year":"2018","unstructured":"Rianna C, Kumar P, Radmacher M. The role of the microenvironment in the biophysics of cancer. Semir Cell Dev Biol. 2018;73:107\u201314.","journal-title":"Semir Cell Dev Biol"},{"key":"68_CR54","first-page":"1","volume":"31","author":"S Lembo","year":"2017","unstructured":"Lembo S, Balato N, Caiazzo G, Megna M, Ayala F, Balato A. The effects of etanercept on replication, proliferation, survival and apoptosis markers in moderate to severe psoriasis. JEADV. 2017;31:1\u201360.","journal-title":"JEADV"},{"issue":"1","key":"68_CR55","first-page":"6","volume":"2","author":"A Bo\u017cek","year":"2016","unstructured":"Bo\u017cek A, Reich A. How to reliably evaluate the severity of psoriasis? Forum Dermatol. 2016;2(1):6\u201311.","journal-title":"Forum Dermatol"},{"issue":"4","key":"68_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis. 2018;35(4):309\u201318.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"68_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1208\/s12248-016-0018-8","volume":"19","author":"S Bian","year":"2017","unstructured":"Bian S, Ferrante M, Gils A. Validation of a drug-resistant anti-adalimumab antibody assay to monitor immunogenicity in the presence of high concentrations of adalimumab. AAPS J. 2017;19(2):468\u201374.","journal-title":"AAPS J"},{"key":"68_CR58","first-page":"1016","volume":"28","author":"A Balato","year":"2014","unstructured":"Balato A, Schiattarella M, Di Caprio R, Lembo S, Mattii M, Malato N, et al. Effects of Adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway. JEADV. 2014;28:1016\u201324.","journal-title":"JEADV"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00068-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-020-00068-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00068-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T14:04:43Z","timestamp":1650117883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-020-00068-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00068-4","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"7 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}